A German pharmaceutical company says it will be partnering with Canadian cannabis nursery Mother Labs to bring a line of branded cannabis flower to the German medical market.
ADREXpharma is a licensed wholesale distributor of controlled drugs and medical cannabis serving most of Germany’s 20,000 pharmacies. New legislation that came into force on April 1, 2024, removed medical cannabis from the German narcotic list, making access easier for Germans seeking to access cannabis for medical purposes.
Cannabis for medical purposes is available at pharmacies in Germany by prescription. Several Canadian cannabis companies have entered the German market in recent years as the country’s medical cannabis program has expanded, increasing demand for products.
In 2019, ADREXpharma announced a deal with Canadian cannabis producer MediPharmm Labs to supply cannabis concentrate derivative products, including THC and CBD oil, to the German market. Earlier this year, the German pharmaceutical company announced a similar deal with a Danish medical cannabis producer to supply cannabis oil through ADREXpharma.
This newest collaboration with Canadian cannabis company Mother Labs will help meet the evolving demands of the German cannabis market, says Nicole Broockmann, CEO of ADREXpharma.
“This partnership represents a significant milestone in our mission to provide German medical patients with the highest quality cannabis products. Mother Labs’ advanced genetic development capabilities perfectly complement our distribution and regulatory expertise. Together, we will bring a product to market that meets the highest standards of quality and consistency.”
The new “Mother Labs” branded cannabis flower is expected to soon be available in German pharmacies.
“We are excited to bring our advanced genetics to Germany in partnership with ADREXpharma,” said Brian Bain, CEO of Mother Labs. “Our purpose-built facility, with dedicated pheno-hunting space and comprehensive storage via our TC lab, allows us to rigorously test all genetics in-house for a minimum of 72 weeks before release. This precision process ensures that only the highest quality, stable, and unique genetics make it to market, reinforcing our position as leaders in genetic innovation.”
Bain told StratCann that the first run of genetics Mother Labs will provide into the German market will be Beta808 (Slurricane x Chatterbox) and Garlic Funk (First Class Funk x GMO). The second will be Tangerine Skies (Wedding Cake x Banjo), Orange Drink, King Z, and Flawless Victory (Ice Cream Cake x Cherry Cheese Cake). Mother Labs bred all of these cultivars, Bain says, except for Orange Drink.
“Over the past year or two, we’ve made significant strides in securing tighter control over our intellectual property, particularly our unique genetics. Rather than broadly releasing certain genetics in the Canadian market, we’ve been selective, tightly controlling which cultivators are initially proving out these genetics domestically and tightening up our terms around domestic and international sales. This approach ensures we maintain the strongest possible grip on our IP as we expand globally.”
Germany has become one of the newest countries to see a ramp-up of cannabis imports from Canada, with brands and producers either teaming up with local companies like ADREXpharma or through their own footprint in Germany, like Aurora and Tilray.
